SCHEMBL6353191

SCHEMBL6353191

COc1cc(C(=O)Nc2ccc(Br)cc2C(=O)O)ccc1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
AKR1C2 P52895 5/20 0.58
AKR1C1 Q04828 5/20 0.58
AKR1C4 P17516 2/20 0.58
AKR1C3 P42330 2/20 0.58
CHEK1 O14757 1/20 0.57
PIM1 P11309 1/20 0.57
MAPK8 P45983 1/20 0.57
CLK4 Q9HAZ1 1/20 0.57
TDP1 Q9NUW8 3/20 0.57
ABL1 P00519 2/20 0.57
RIN1 Q13671 2/20 0.57
MAPT P10636 4/20 0.56
RAB9A P51151 3/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
NPC1 O15118 2/20 0.53
POLB P06746 1/20 0.53
KCNK2 O95069 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6349632 0.90 CHEK1 (0.70) LMNASMN1; SMN2AKR1C2AKR1C1AKR1C4
SCHEMBL6349404 0.85 LMNA (0.81) LMNASMN1; SMN2AKR1C2AKR1C1AKR1C4
SCHEMBL15702354 0.85 ABL1 (0.79) LMNASMN1; SMN2AKR1C2AKR1C1AKR1C4
SCHEMBL6360748 0.84 AKR1C2 (0.60) LMNASMN1; SMN2AKR1C2AKR1C1AKR1C4
SCHEMBL6359133 0.83 AKR1C2 (0.68) LMNASMN1; SMN2AKR1C2AKR1C1AKR1C4
SCHEMBL6352362 0.82 CHEK1 (0.54) LMNAAKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6349859 0.82 MAPT (0.76) LMNASMN1; SMN2AKR1C2AKR1C1AKR1C4
SCHEMBL17166275 0.81 AKR1C2 (0.73) AKR1C2AKR1C1AKR1C4AKR1C3TDP1
SCHEMBL6350824 0.81 KCNK2 (0.62) LMNASMN1; SMN2AKR1C2AKR1C1AKR1C4
SCHEMBL6353682 0.81 AKR1C2 (0.71) LMNAAKR1C2AKR1C1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 LMNA 4552/4885SMN1; SMN2 3015/4885AKR1C2 3012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.